𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of gynecological malignancies with a combination of cisplatin, Adriamycin and ifosfamide

✍ Scribed by Takashi Nishida; Naoki Nagasue; Michiaki Yakushiji


Publisher
Springer
Year
1990
Tongue
English
Weight
342 KB
Volume
26
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Treatment of advanced ovarian cancer: A
✍ Bezwoda, W. R. πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 395 KB

Fifty-one patients with ovarian cancer were tients with < 2 cm residual disease had sigentered in a randomised trial comparing treat-nificantly higher rate of complete remission rnent with cisplatin + adriamycin + cyclo-than those with > 2 crn residual disease. Carphosphamide (PAC) to cisplatin + 4'

Treatment of advanced malignant hemangio
✍ C. F. Beadle; B. L. Hillcoat πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 400 KB

One patient with a large inoperable malignant hemangiopericytoma and three patients with local recurrence and/or metastases were treated with combination adriamycin, 50 mg/m2, and DTIC, 600-700 mg/m2, intravenously every 4 weeks. Two achieved palliation, one with measurable shrinkage of tumor, and t

The efficacy of a combination of etoposi
✍ Zs. PΓ‘pai; Gy. Bodoky; J. SzΓ‘ntΓ³; I. Poller; P. RahΓ³ty; S. Eckhardt; I. LΓ‘ng; M. πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 62 KB πŸ‘ 2 views

## BACKGROUND. Successful chemotherapy for patients with soft tissue sarcoma (STS) has been limited by a lack of active drugs. The most effective single agents are doxorubicin, dacarbazine, and, more recently, ifosfamide. Previously the most widely used combination has been CYVADIC (cyclophosphami